BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28114277)

  • 1. The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
    Hermanns C; Hampl V; Holzer K; Aigner A; Penkava J; Frank N; Martin DE; Maier KC; Waldburger N; Roessler S; Goppelt-Struebe M; Akrap I; Thavamani A; Singer S; Nordheim A; Gudermann T; Muehlich S
    Oncogene; 2017 Jun; 36(24):3464-3476. PubMed ID: 28114277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.
    Hampl V; Martin C; Aigner A; Hoebel S; Singer S; Frank N; Sarikas A; Ebert O; Prywes R; Gudermann T; Muehlich S
    EMBO Mol Med; 2013 Sep; 5(9):1367-82. PubMed ID: 23853104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
    Cen B; Selvaraj A; Prywes R
    J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoferlin is a key regulator of EGFR activity in breast cancer.
    Turtoi A; Blomme A; Bellahcène A; Gilles C; Hennequière V; Peixoto P; Bianchi E; Noel A; De Pauw E; Lifrange E; Delvenne P; Castronovo V
    Cancer Res; 2013 Sep; 73(17):5438-48. PubMed ID: 23864327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of serum response factor in hepatocellular carcinoma: implications for disease progression.
    Kwon CY; Kim KR; Choi HN; Chung MJ; Noh SJ; Kim DG; Kang MJ; Lee DG; Moon WS
    Int J Oncol; 2010 Oct; 37(4):837-44. PubMed ID: 20811705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.
    Muehlich S; Hampl V; Khalid S; Singer S; Frank N; Breuhahn K; Gudermann T; Prywes R
    Oncogene; 2012 Aug; 31(35):3913-23. PubMed ID: 22139079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent.
    Selvaraj A; Prywes R
    BMC Mol Biol; 2004 Aug; 5():13. PubMed ID: 15329155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
    Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S
    Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus.
    Yadav A; Kumar B; Lang JC; Teknos TN; Kumar P
    Oncogene; 2017 Nov; 36(46):6374-6382. PubMed ID: 28745314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
    Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
    Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of myoferlin in human and murine carcinoma tumors: role in membrane repair, cell proliferation, and tumorigenesis.
    Leung C; Yu C; Lin MI; Tognon C; Bernatchez P
    Am J Pathol; 2013 May; 182(5):1900-9. PubMed ID: 23499551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma.
    Mittermeier C; Konopa A; Muehlich S
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.
    Zhu W; Zhou B; Zhao C; Ba Z; Xu H; Yan X; Liu W; Zhu B; Wang L; Ren C
    J Cell Mol Med; 2019 Nov; 23(11):7180-7189. PubMed ID: 31475450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis.
    Qian T; Liu C; Ding Y; Guo C; Cai R; Wang X; Wang R; Zhang K; Zhou L; Deng Y; Wu C; Sun Y
    Oncogene; 2020 Mar; 39(10):2069-2087. PubMed ID: 31801973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of SRF-dependent gene expression by association of SPT16 with MKL1.
    Kihara T; Kano F; Murata M
    Exp Cell Res; 2008 Feb; 314(3):629-37. PubMed ID: 18036521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.
    Blomme A; Fahmy K; Peulen O; Costanza B; Fontaine M; Struman I; Baiwir D; de Pauw E; Thiry M; Bellahcène A; Castronovo V; Turtoi A
    Oncotarget; 2016 Dec; 7(50):83669-83683. PubMed ID: 27845903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.
    Rademaker G; Hennequière V; Brohée L; Nokin MJ; Lovinfosse P; Durieux F; Gofflot S; Bellier J; Costanza B; Herfs M; Peiffer R; Bettendorff L; Deroanne C; Thiry M; Delvenne P; Hustinx R; Bellahcène A; Castronovo V; Peulen O
    Oncogene; 2018 Aug; 37(32):4398-4412. PubMed ID: 29720728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death.
    Saran S; Tran DD; Ewald F; Koch A; Hoffmann A; Koch M; Nashan B; Tamura T
    Oncogene; 2016 Jul; 35(29):3872-9. PubMed ID: 26549021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress.
    Asparuhova MB; Ferralli J; Chiquet M; Chiquet-Ehrismann R
    FASEB J; 2011 Oct; 25(10):3477-88. PubMed ID: 21705668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.